Literature DB >> 8667629

Cancer of the low and middle rectum: local and distant recurrences, and survival in 350 radically resected patients.

F Bozzetti1, L Mariani, R Miceli, R Doci, F Montalto, S Andreola, L Gennari.   

Abstract

The purpose of this study was to compare local recurrence, distant metastases, and survival rate in 350 patients with cancer of the middle and low rectum who underwent a radical abdominoperineal resection (APER) or a sphincter-saving resection (SSR) in our Institute. There were 257 APER patients and 93 SSR patients, with a median follow-up of 77 months. At 5 years, the estimates in APER and SSR patients were respectively 11% and 30% for the incidence of pelvic recurrence, 18% and 8% for the incidence of distant metastases, and 64% and 73% for overall survival. In the multivariate analysis it was found that Dukes' stage significantly affected pelvic recurrences, distant metastases rate and overall survival; histologic type affected only the pelvic recurrence rate. However, the final outcome of patients following APER or SSR was similar, suggesting that local failure per se does not affect long-term survival.

Entities:  

Mesh:

Year:  1996        PMID: 8667629     DOI: 10.1002/(SICI)1096-9098(199607)62:3<207::AID-JSO11>3.0.CO;2-3

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  External coloanal anastomosis without covering stoma in low-lying rectal cancer.

Authors:  Ashraf Abdel-Azeem Mohamed; Abdel-Fatah Saleh Abdel-Fatah; Khaled Mohamed Mahran; Abo-Bakr Mohamed Mohie-Eldin
Journal:  Indian J Surg       Date:  2010-11-16       Impact factor: 0.656

2.  Hand-sewn coloanal anastomosis for distal rectal cancer: long-term clinical outcomes.

Authors:  Seung Hyuk Baik; Nam Kyu Kim; Kang Young Lee; Seung Kook Sohn; Chang Hwan Cho
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

3.  Distribution of lymph nodes in the mesorectum: how deep is TME necessary?

Authors:  R O Perez; V E Seid; E H Bresciani; C Bresciani; I Proscurshim; D D Pereira; D Kruglensky; V Rawet; A Habr-Gama; D Kiss
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

4.  The site of the tumor, not the type of operation, determines the worse prognosis of the low rectal cancer.

Authors:  Federico Bozzetti
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Update and debate issues in surgical treatment of middle and low rectal cancer.

Authors:  Nam Kyu Kim; Min Sung Kim; Sami F Al-Asari
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31

Review 6.  Carbon-ion Radiotherapy for Colorectal Cancer.

Authors:  Shigeru Yamada; Hirotoshi Takiyama; Yuka Isozaki; Makoto Shinoto; Hirokazu Makishima; Naoyoshi Yamamoto; Hiroshi Tsuji
Journal:  J Anus Rectum Colon       Date:  2021-04-28

7.  Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation.

Authors:  Shigeru Yamada; Hirotoshi Takiyama; Yuka Isozaki; Makoto Shinoto; Daniel K Ebner; Masashi Koto; Hiroshi Tsuji; Hideaki Miyauchi; Mitsugu Sekimoto; Hideki Ueno; Michio Itabashi; Masataka Ikeda; Hisahiro Matsubara
Journal:  Ann Surg Oncol       Date:  2021-10-18       Impact factor: 5.344

8.  The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.

Authors:  Xin Cai; Yueyao Du; Zheng Wang; Ping Li; Zhan Yu; Qing Zhang; Zhen Zhang
Journal:  Radiat Oncol       Date:  2020-08-28       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.